SLC5A2 and diabetic kidney disease: Because we found a predominant tubulointerstitial expression of SLC5A2 in both healthy controls and diabetic nephropathy, we next analyzed the association between tubulointerstitial SLC5A2 mRNA expression levels, focusing on various complement components and receptors.